Literature DB >> 32444334

Diffusion-weighted magnetic resonance imaging in the characterization of odontogenic cysts and tumors.

Rajesh Vanagundi1, Jyoti Kumar2, Alpana Manchanda1, Sujata Mohanty3, Ravi Meher4.   

Abstract

OBJECTIVES: The aim of this study was to evaluate diffusion-weighted imaging (DWI) in comparison with morphologic magnetic resonance imaging (MRI) in differentiating among odontogenic keratocyst (OKC), unicystic ameloblastoma (UAB), and dentigerous cyst (DC). STUDY
DESIGN: Contrast-enhanced MRI, including DWI, was performed on 27 patients with the 3 lesions. Signal intensity characteristics were evaluated on T1- and T2-weighted MRI. The apparent diffusion coefficient (ADC) cutoff value to most effectively differentiate among the 3 lesions was calculated with receiver operating characteristic analysis.
RESULTS: In total, 17 OKCs, 5 UABs, and 5 DCs were diagnosed histologically. There were no significant differences among them in signal intensity on T1- or T2-weighted images (P ≥ .13). On DWI, 14 of 17 OKCs showed restricted diffusion with a mean ADC value of 0.954 × 10-3 mm2/s. All 5 UABs and all 5 DCs exhibited facilitated diffusion with ADC values ≥ 2.150 × 10-3 mm2/s. The ADC cutoff to differentiate OKCs from UABs was 2.137 × 10-3 mm2/s (P = .01); UABs from DCs was 2.422 × 10-3 mm2/s (P = .03); and OKCs from DCs was 2.347 × 10-3 mm2/s (P = .01).
CONCLUSIONS: Addition of diffusion-weighted sequences to MRI jaw protocols can assist in the characterization of OKCs, UABs, and DCs.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32444334     DOI: 10.1016/j.oooo.2020.04.010

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  1 in total

1.  Differentiation of cystic lesions in the jaw by conventional magnetic resonance imaging and diffusion-weighted imaging.

Authors:  Natnicha Wamasing; Hiroshi Watanabe; Junichiro Sakamoto; Hiroshi Tomisato; Tohru Kurabayashi
Journal:  Dentomaxillofac Radiol       Date:  2021-06-16       Impact factor: 2.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.